Better Health for All

McKesson's core business of distributing pharmaceuticals and medical supplies inherently provides substantial health benefits. The company actively enhances this positive impact through initiatives such as preventing opioid diversion

, launching Project Oasis to address pharmacy deserts in underserved communities , supporting cancer patients , and acquiring Rx Savings Solutions to enhance affordability for over 17 million patients . McKesson does not hold healthcare-related patents or produce food products. The McKesson Foundation awarded over $4.1 million to pharmacy schools to increase diversity in the pharmacy workforce, supporting student development, professional development, and community outreach programs aimed at improving health outcomes for vulnerable populations .

Fair Money & Economic Opportunity

McKesson Corporation is a healthcare services company, primarily distributing pharmaceuticals and medical supplies. The "Fair Money & Economic Opportunity" value assesses activities related to lending, insuring, moving, or storing money for consumers. As McKesson does not offer consumer lending, deposit services, or other financial products, all KPIs within this value are not applicable to its core business operations. McKesson has faced significant penalties, including over $432 million for price-fixing or anti-competitive practices

and over $456 million for False Claims Act violations . These relate to its healthcare and government contracting activities, not to consumer financial products or services. The company provided $6 million in grants to charities in FY2023 and supports initiatives like Project Oasis to facilitate independent pharmacy ownership in underserved communities , and enhances supplier diversity for small and diverse businesses . However, these activities, while contributing to economic opportunity, do not align with the specific financial services metrics of the KPIs, such as share of a loan book or revenue from high-cost financial products. Therefore, all KPIs are scored as 0, indicating non-applicability to the company's business model.

Fair Pay & Worker Respect

McKesson Corporation's CEO-to-median employee pay ratio was 295:1 for fiscal year 2025.

In November 2024, a subsidiary agreed to pay $448,578 in back wages and interest to nearly 900 Black, Hispanic, and white applicants to resolve allegations of hiring discrimination at a Texas distribution facility between September 2019 and September 2021. Workers at a Missouri facility went on strike in May 2025, citing low pay, mandatory overtime, and lack of respect. In December 2023, warehouse workers in California voted to authorize a strike over inadequate health care benefits and insufficient pay. Despite these issues, McKesson was recognized on Newsweek’s 2023 list of 'America's Greatest Workplaces for Diversity' with a 5-star rating.

Fair Trade & Ethical Sourcing

McKesson has implemented blockchain technology across 1,200 distribution points, enabling real-time verification for 98.6% of shipments, which enhances supply chain transparency.

For the fiscal year ending March 31, 2025, and in its 2024 report, no incidents of forced or child labor were identified. The company assesses modern slavery risks, provides mandatory annual Code of Conduct training to all employees and contractors, and offers an Integrity Line for reporting concerns.

Honest & Fair Business

McKesson incurred approximately $8.45 billion in ethics-related regulatory fines between 2021 and 2024.

This includes an $8.001 billion fine in 2021 for off-label or unapproved promotion of medical products, along with other penalties in 2022 for off-label promotion, product safety violations, and Controlled Substances Act violations. The company's S&P Global ESG Score is 34. McKesson's Code of Conduct, last amended in November 2024, includes provisions for whistleblower protection and an Integrity Line available 24/7. However, a federal appeals court revived a lawsuit in March 2024 by a former executive alleging kickbacks and destruction of documents. The company also states it has a zero-tolerance policy towards corruption and bribery, detailing policies that prohibit improperly influencing business conduct to ensure compliance with anti-bribery and anti-corruption laws.

Kind to Animals

No specific evidence was found in the provided articles regarding McKesson Corporation's performance on animal welfare. The articles primarily focus on modern slavery, human trafficking, and general environmental sustainability (e.g., carbon neutrality, responsible sourcing program addressing labor and environmental protection), which do not directly address the specific KPIs related to animal testing, cruelty-free certifications, humane operations, wildlife conservation impact, ethical input substitution, or animal agriculture ethics. McKesson has set a target to achieve carbon neutrality by 2040

, demonstrating its commitment to reducing environmental impact . The company is investing in energy-efficient technologies and optimizing fleet routing to reduce emissions . Therefore, all KPIs are omitted due to lack of relevant data.

No War, No Weapons

McKesson Corporation is a participant in the United Nations Global Compact initiative

, committing to support its 10 principles , which include human rights, labor, environment, and anti-corruption .

Planet-Friendly Business

McKesson received approval from the Science Based Targets initiative (SBTi) for its near-term climate change targets in January 2023.

The company committed to reducing absolute Scope 1 and 2 greenhouse gas emissions by 50.4% by fiscal year 2032, using fiscal year 2020 as the base year. McKesson has implemented energy efficiency projects, including lighting upgrades across 26 locations, projected to avoid 2,730 metric tons of CO₂ emissions over the next decade. A 1.1 megawatt rooftop solar array at its West Sacramento center generated over two-thirds of that facility’s annual electricity consumption in its first year. In November 2020, McKesson joined the United Nations Global Compact initiative.

Respect for Cultures & Communities

McKesson, along with other companies, reached a $75 million settlement with the Cherokee Nation on September 28, 2021, to address opioid-related claims.

This agreement was part of broader negotiations with Native American tribes to resolve opioid-related issues. , indicating a reactive response to community concerns.

Safe & Smart Tech

McKesson allocated $275 million to enhance its cybersecurity infrastructure in 2023.

Compared to its 2022 revenue of $264 billion, this represents approximately 0.104% of revenue. The company reported a 99.7% prevention rate of potential data breaches in 2023, effectively protecting 375 million patient records, indicating no documented breaches in the past three years. For patient privacy, McKesson works exclusively with deidentified data for data commercialization and advanced analytics, and its Vulnerability Disclosure Program explicitly prohibits the collection or sharing of personally identifiable information. The company maintains compliance with global regulations including HIPAA, GDPR, CCPA, and the Drug Supply Chain Security Act, incurring significant expense to do so. McKesson operates a Vulnerability Disclosure Program but explicitly states that it does not offer bounties or rewards to researchers.

Zero Waste & Sustainable Products

McKesson has implemented several initiatives to reduce waste and enhance product sustainability. In 2023, the company achieved 68.3% recyclability for its packaging materials

. It also reduced plastic in its packaging by 17.6% and overall packaging waste by 22.3% . McKesson invested $14.7 million in sustainable packaging technologies , implemented a reusable system for transporting cold chain products , and launched its Foster & Thrive private brand with an aluminum product line featuring infinitely recyclable packaging that reduces plastic usage by 70% for that line .